Exelixis Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Good day, everybody. Thanks for joining us at the Virtual Bank of America Annual Health Care Conference. I am Jason Gerberry, SMID cap biotech analyst, and I'm pleased to be introducing our next company presenter, Exelixis and CEO, Mike Morrissey. So Mike, thanks so much for joining us once again.
It's great to be here, Jason. Thanks again for the invite. Just before we begin, I'll remind everybody that I'm making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business.
Questions & Answers
Great. So I guess, first off, what a difference a year makes. About a year ago, we were talking about the kinetics of renal cancer market and how that was leading to a decline in CABOMETYX. And now CABOMETYX is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |